Closing Bell: Fennec Pharmaceuticals Inc down on Wednesday (FRX)

Today during trading, Fennec Pharmaceuticals Inc opened at $9.18 and closed at $9.10. Intraday prices ranged from a low of $9.00 to a high of $9.18.

Shares eased -0.55% from the previous day's close of $9.15.

Today across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Fennec Pharmaceuticals Inc traded under FRX on the Toronto Stock Exchange (TSX).

Trading volume was 1,202 on 13 total trades, with an average volume of 3,030 over the last 5 days.

The TSX overall saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, in the last 12 months, Fennec Pharmaceuticals Inc's shares have shrunken -21.89 percent, while they have shrunken -39.97% this year.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $250.00 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a None company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc has an average recommendation of "Strong Buy" based on 6.00 analysts according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..